The efficacy, safety and cost-effectiveness of hydroxychloroquine, sulfasalazine, methotrexate triple therapy in preventing relapse among patients with rheumatoid arthritis achieving clinical remission or low disease activity: the study protocol of a randomized controlled clinical Trial (ESCoRT study)

BACKGROUND: Tumor necrosis factor α inhibitors (TNFi) is effective for rheumatoid arthritis (RA) patients who fail to conventional synthetic disease-modifying anti-rheumatic drugs (csDMARDs). Because of high cost, the discontinuation is common but often lead to disease relapse. The study aims to inv...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Juan, Zhou, Wei, Wu, Yangfeng, Ji, Ping, Yang, Li, Yan, Xiaoyan, Zhang, Zhuoli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7934358/
https://www.ncbi.nlm.nih.gov/pubmed/33663487
http://dx.doi.org/10.1186/s12911-021-01449-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7934358/
https://www.ncbi.nlm.nih.gov/pubmed/33663487
http://dx.doi.org/10.1186/s12911-021-01449-2

Ejemplares similares